Middle Meningeal Artery Embolization for Chronic Subdural Hematoma Related to Autosomal Dominant Polycystic Kidney Disease

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2023 Mar 20

PMID 36938171

Authors

Hayes B Fountain

Bernardo A de Monaco

Jonathan Jagid

Ronald Benveniste

Joacir G Cordeiro

Affiliations

Soon will be listed here.

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is a connective tissue disease with vascular abnormalities involving multiple organs. The prevalence of ADPKD associated with a spontaneous subdural hematoma (SDH) is very low, with less than 10 cases reported in the literature to date. Symptomatic chronic SDH is classically treated with a twist drill, burr holes, or craniotomy. Recently, middle meningeal artery (MMA) embolization has emerged as an ancillary modality. We present the first case in the literature of a bilateral SDH in a young ADPKD patient successfully managed with MMA embolization. Moreover, we discuss the role of different treatment modalities on this subset of patients.

References

Torres V, Harris P, Pirson Y . Autosomal dominant polycystic kidney disease. Lancet. 2007; 369(9569):1287-1301. DOI: 10.1016/S0140-6736(07)60601-1. View

Ng S, Derraz I, Boetto J, Dargazanli C, Poulen G, Gascou G . Middle meningeal artery embolization as an adjuvant treatment to surgery for symptomatic chronic subdural hematoma: a pilot study assessing hematoma volume resorption. J Neurointerv Surg. 2019; 12(7):695-699. DOI: 10.1136/neurintsurg-2019-015421. View

Tan A, Blumenfeld J, Michaeel A, Donahue S, Bobb W, Parker T . Autosomal dominant polycystic kidney disease caused by somatic and germline mosaicism. Clin Genet. 2014; 87(4):373-7. DOI: 10.1111/cge.12383. View

Gabow P . Autosomal dominant polycystic kidney disease. N Engl J Med. 1993; 329(5):332-42. DOI: 10.1056/NEJM199307293290508. View

Feghali J, Yang W, Huang J . Updates in Chronic Subdural Hematoma: Epidemiology, Etiology, Pathogenesis, Treatment, and Outcome. World Neurosurg. 2020; 141:339-345. DOI: 10.1016/j.wneu.2020.06.140. View

Loghman-Adham M, Soto C, Inagami T, Cassis L . The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease. Am J Physiol Renal Physiol. 2004; 287(4):F775-88. DOI: 10.1152/ajprenal.00370.2003. View

Wijdicks E, Torres V, Schievink W . Chronic subdural hematoma in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2000; 35(1):40-3. DOI: 10.1016/S0272-6386(00)70299-X. View

Catapano J, Nguyen C, Wakim A, Albuquerque F, Ducruet A . Middle Meningeal Artery Embolization for Chronic Subdural Hematoma. Front Neurol. 2020; 11:557233. PMC: 7606850. DOI: 10.3389/fneur.2020.557233. View

Gabow P . Autosomal dominant polycystic kidney disease--more than a renal disease. Am J Kidney Dis. 1990; 16(5):403-13. DOI: 10.1016/s0272-6386(12)80051-5. View

10.

Schievink W, Torres V, Piepgras D, Wiebers D . Saccular intracranial aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1992; 3(1):88-95. DOI: 10.1681/ASN.V3188. View

11.

Holthouse D, Wong G . Chronic subdural hematoma in a 50-year-old man with polycystic kidney disease. Am J Kidney Dis. 2001; 38(2):E6. DOI: 10.1053/ajkd.2001.26116. View

12.

Leung G, Fan Y . Chronic subdural haematoma and arachnoid cyst in autosomal dominant polycystic kidney disease (ADPKD). J Clin Neurosci. 2005; 12(7):817-9. DOI: 10.1016/j.jocn.2004.09.025. View

13.

Kaestner S, van den Boom M, Deinsberger W . Frequency of and Risk Factors for Chronification in Traumatic Acute Subdural Hematoma following Conservative Therapy. J Neurol Surg A Cent Eur Neurosurg. 2019; 80(5):359-364. DOI: 10.1055/s-0039-1685188. View

14.

Vega R, Valadka A . Natural History of Acute Subdural Hematoma. Neurosurg Clin N Am. 2017; 28(2):247-255. DOI: 10.1016/j.nec.2016.11.007. View

15.

Davenport M, Perazella M, Yee J, Dillman J, Fine D, McDonald R . Use of Intravenous Iodinated Contrast Media in Patients With Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation. Kidney Med. 2020; 2(1):85-93. PMC: 7525144. DOI: 10.1016/j.xkme.2020.01.001. View